i

Help us improve the data and information in HERDIN.


HERDIN record number : PCHRD08011103085351

2. Provide us with additional details
Report an error   
Advanced Search

Effect of topical ketorolac tromethamine and topical nepafenac on maintaining pupillary dilation during phacoemulsification.

Author

Richard Antanis,
Prospero Ma. Tuaño,
Jay  Vicencio,
Jose Ma.  Martinez,
Lee Verzosa

Related Institution

International Eye Institute - St. Luke's Medical Center

Publication Information

Publication Type
Journal
Publication Sub Type
Journal Article, Original
Title
Philippine Journal of Ophthalmology
Frequency
Semi-Annual
Publication Date
January-June 2011
Volume
36
Issue
1
Page(s)
23-27

Abstract

Methods
This is a prospective, randomized, double-masked comparative study involving adult cataract patients given topical NSAIDs (ketorolac or nepafenac) or balanced salt solution (control) prior to phacoemulsification and capsular bag intraocular-lens (IOL) implantation at a tertiary hospital. Horizontal and vertical diameters of pupil were measured at different stages of cataract surgery and the mean values were compared across the three groups.

Results
A total of 47 eyes of 44 cataract surgery patients, 13 males and 34 females, with a mean age of 66.04 ± 8.87 years, were included in the study. The mean horizontal and vertical diameters of the three groups were similar at the start of surgery. Significant differences were seen after IOL implantation, with the nepafenac group having the largest mean diameters in both horizontal (p = 0.012) and vertical (p = 0.012) pupil measurements.

Conclusion
Topical nepafenac has been shown to be a more effective inhibitor of miosis during phacoemulsification and provides a more stable mydriatic effect throughout the surgical procedure compared to topical ketorolac and placebo.

Objectives

This study compared the effectiveness of prophylactic administration of topical ketorolac tromethamine 0.5% and nepafenac 0.1% on maintaining mydriasis during phacomulsification.

References

1. Linebarger, EJ , Hardten, DR , Shah, GK , et al, . "Phacoemulsification and modern cataract surgery" Surv Ophthalmol 44(2): 123-147., September 1999-October 1999. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/10541151
2. Gogate, PM , Kulkarni, SR , Krishnaiah, S , et al, . "Safety and efficacy of phacoemulsification compared with manual small-incision cataract surgery by a randomized controlled clinical trial: six-week results" Ophthalmology 112(5): 869-874, May 2005. Retrieved from: http://www.v2020la.org/pub/PUBLICATIONS_BY_TOPICS/Cataract/Safety%20and%20Efficacy....pdf
3. Riaz, Y , Mehta, JS , Wormald, R , et al, . "Surgical interventions for age-related cataract" Cochrane Database Syst Rev 18(4): CD001323, October 2006. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/17054134
4. Gupta, VP , Dhaliwal, U , Prasad, N . "Ketorolac tromethamine in the maintenance of intraoperative mydriasis" Ophthalmic Surg Lasers 28(9): 731-738, September 1997. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/9304635
5. Solomon, K , Turkalj, JW , Whiteside, SB . "Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery" Arch Ophthalmol 115(9): 1119-1122, September 1997. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/9298051
6. Cervantes-Coste, G , Sanchez-Castro, YG , Orozco-Carroll, M , et al, . "Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac" Clin Ophthalmol 3, 219-226, 2009. Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708994/
7. Duffin, RM , Camras, CB , Gardner, SK , et al, . "Inhibitors of surgically induced miosis" Ophthalmology 89(8): 966-977, August 1982. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/7133642
8. Podos, SM . "Prostaglandins, nonsteroidal antiinflammatory agents and eye disease" Trans Am Ophthalmol Soc 74, 637-660, 1976. Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1311530/
9. Flach, AJ , Lavelle, CJ , Olander, KW , et al, . "The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular-lens implantation. " Ophthalmology 95(9): 1279-1284, September 1988. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/3062540
10. (). Ophthalmic Nonsteroidal Anti Inflammatory Drugs Drug Class Review. July 2009. . Retrieved from: http://vaww.pbm.va.gov (accessed Feb 222010)
11. (). Ophthalmic NSAIDs Review. Sept 2008. . Retrieved from: http://https://nevada.fhsc.com/Downloads/ provider/NVRx_DCR_20090326_Ophthalmic_NSAIDs.pdf (accessed Oct 32010)
12. Bucci, FA Jr, Waterbury, LD , Amico, LM , et al, . "Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (Acular LS) and nepafenac 0.1% (Nevanac) in patients undergoing phacoemulsification" Am J Ophthalmol 144(1): 146-147, July 2007. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/17601444

Physical Location

LocationLocation CodeAvailable FormatAvailability
Philippine Academy of Ophthalmology Abstract External Link (View)
Philippine Council for Health Research and Development Library Box No. 62 Fulltext Print Format

 
Loading…
©2022 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date